DeepMed Research

HEIDELBERG UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1386-01-01

Employees: -

Market Cap: -

Website: https://www.uni-heidelberg.de/

Clinical Trials

Anesthesia Depth Increases Delirium Incidence

Not Applicable

Completed

Conditions: Anesthesia Awareness
Delirium

Interventions: Device: BIS guidance of anesthesia
Other: Standard of Care

First Posted Date: 2022-12-19

Last Posted Date: 2022-12-19

Lead Sponsor: Heidelberg University

Target Recruit Count: 130

Registration Number: NCT05656703

Locations: 🇩🇪
Clinic of Anesthesiology and Critical Care Medicine, Faculty of Clinical Medicine MAnnheim, University of Heidelberg, Germany, Mannheim, Baden-Wuerttemberg, Germany

Training in HFpEF-PH

Not Applicable

Not yet recruiting

Conditions: Heart Failure With Preserved Ejection Fraction
Pulmonary Hypertension Due to Left Heart Disease

Interventions: Other: Exercise rehabilitation
Other: Standard treatment

First Posted Date: 2022-07-19

Last Posted Date: 2022-09-16

Lead Sponsor: Heidelberg University

Target Recruit Count: 90

Registration Number: NCT05464238

Locations: 🇩🇪
Centre for Pulmonary Hypertension at the Thoraxklinik Heidelberg, Heidelberg University Hospital, Heidelberg, Germany
🇱🇹
Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania, Vilnius, Lithuania

Depth of Anesthesia and Proteomics

Not Applicable

Completed

Conditions: Anesthesia Complication
Immune Suppression

Interventions: Drug: Shallow anesthesia
Drug: Deep anesthesia

First Posted Date: 2022-05-19

Last Posted Date: 2022-05-19

Lead Sponsor: Heidelberg University

Target Recruit Count: 18

Registration Number: NCT05380778

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH

Phase 2

Recruiting

Conditions: Pulmonary Vascular Disorder
Systemic Sclerosis
Other Systemic Involvement of Connective Tissue
Primary Pulmonary Hypertension

Interventions: Drug: Riociguat Oral Tablet
Other: Placebo

First Posted Date: 2022-04-21

Last Posted Date: 2024-12-16

Lead Sponsor: Heidelberg University

Target Recruit Count: 70

Registration Number: NCT05339087

Locations: 🇦🇹
LKH-Univ. Klinikum Graz Universitätsklinik für Innere Medizin Klinische Abteilung für Pulmonologie, Graz, Austria
🇦🇹
Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
🇫🇷
Centre de référence des Maladies Auto-Immunes Systémiques rares du Nord et Nord-Ouest (CeRAINO) Service de Médecine Interne et Immunologie Clinique Hôpital Claude Huriez, CHU, Lille, France

and more 5 locations

Oral Health and Severe COPD

Conditions: Periodontitis
Caries
COPD
Quality of Life
Tooth Loss

First Posted Date: 2022-04-05

Last Posted Date: 2022-04-05

Lead Sponsor: Heidelberg University

Target Recruit Count: 104

Registration Number: NCT05311657

Locations: 🇩🇪
University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany

Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody

Phase 3

Recruiting

Conditions: Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a

Interventions: Drug: Standard
Drug: Experimental

First Posted Date: 2021-09-16

Last Posted Date: 2024-12-06

Lead Sponsor: Heidelberg University

Target Recruit Count: 100

Registration Number: NCT05045664

Locations: 🇩🇪
Vivantes Klinikum Berlin, Berlin, Germany
🇩🇪
University of Essen, Essen, Germany
🇩🇪
University of Göttingen, Göttingen, Germany

and more 9 locations

Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH

Phase 4

Recruiting

Conditions: Primary Pulmonary Arterial Hypertension
Chronic Thromboembolic Pulmonary Hypertension

Interventions: Drug: Riociguat

First Posted Date: 2021-07-08

Last Posted Date: 2024-03-15

Lead Sponsor: Heidelberg University

Target Recruit Count: 30

Registration Number: NCT04954742

Locations: 🇩🇪
Centre for Pulmonary Hypertension at the Thoraxklinik Heidelberg, Heidelberg University Hospital, Heidelberg, Germany

Induction Agent and Incidence of Hypotension in Heart Failure Patients Undergoing LVAD-Implantation

Conditions: Blood Pressure, Low

Interventions: Drug: Etomidate
Drug: Midazolam
Drug: Sevoflurane

First Posted Date: 2021-06-22

Last Posted Date: 2021-10-19

Lead Sponsor: Heidelberg University

Target Recruit Count: 50

Registration Number: NCT04934410

Evaluation of a Web-Based Intervention for Binge Eating Disorder

Not Applicable

Completed

Conditions: Binge Eating Disorder

Interventions: Other: Selfapy for Binge Eating Disorder

First Posted Date: 2021-05-06

Last Posted Date: 2025-03-17

Lead Sponsor: Heidelberg University

Target Recruit Count: 154

Registration Number: NCT04876183

Locations: 🇩🇪
Heidelberg University, Heidelberg, Baden-Württemberg, Germany

Evaluation of a Web-Based Intervention for Bulimia Nervosa

Not Applicable

Completed

Conditions: Bulimia Nervosa

Interventions: Other: Selfapy for Bulimia Nervosa

First Posted Date: 2021-05-06

Last Posted Date: 2025-03-17

Lead Sponsor: Heidelberg University

Target Recruit Count: 152

Registration Number: NCT04876196

Locations: 🇩🇪
Heidelberg University, Heidelberg, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy